VIBIM Study: One-year results of treatment of DME with aflibercept using TnE
5 October 2020
| Sofia Rokerya
|
Retina / Uvea / Vitreous
The VIBIM study (the treat-and-extend regimen (TER) using intravitreal aflibercept in diabetic macular edema (DME) study) was designed to evaluate the efficacy of the TER using aflibercept in the management of DME for a period of two years. The authors...
Conservative surgical management of optic disc pit maculopathy
5 August 2020
| Annes Ahmeidat
|
Retina / Uvea / Vitreous
|
Optic disc pit maculopathy, Vitrectomy, Laser, Gas tamponade, Posterior vitreous detachment
Four cases are presented in this case report that illustrates the option of conservative surgical management for optic disc pit complicated by maculopathy (ODP-M). Four men aged 24-67-years-old with no spontaneous resolution of ODP-M for a minimum of three months,...
Ozurdex in epiretinal membrane surgery
5 August 2020
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
This was a prospective multicentre pilot study, looking at the effect of Ozurdex on visual acuity (VA) and central retinal thickness (CRT) in patients undergoing surgery for epiretinal membrane (ERM). Twelve eyes of 12 patients were included in the study....
Silicone oil in rhegmatogenous retinal detachment
5 June 2020
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
|
Rhegmatogenous retinal detachment, epiretinal membrane, macular edema, optical coherence tomography, silicone oil tamponade
Silicone oil (SO), used in complicated retinal detachments, is associated with complications such as cataract, increased intraocular pressure (IOP), keratopathy, cystoid macular oedema (CMO), epiretinal membrane (ERM) and loss of vision. Emulsification of oil can also lead to migration of...
Anatomical and functional outcomes following switching from aflibercept to ranibizumab in NARMD
5 June 2020
| Jonathan Chan
|
Retina / Uvea / Vitreous
|
clinical trial, degeneration, imaging, macula, neovascularisation
This is a six-month, prospective, single-arm study in the UK and Germany. A total of 100 patients were enrolled (one in the primary failure group, 99 in the suboptimal treatment response group), treated three-monthly intravitreal ranibizumab injections (0.5mg), and then...
Visual outcome and surgical results in children with Marfan Syndrome
5 June 2020
| Ivan Yip
|
Retina / Uvea / Vitreous
|
Marfan syndrome, ectopia lentis, lensectomy, visual and surgical result
Eighty-two eyes of 41 patients with a genetically proven diagnosis of Marfan syndrome were retrospectively analysed. Twenty-seven had bilateral subluxation and 14 received lensectomy. Follow-up was three years. Mean visual acuity (VA) was 0.1 ±0.7 logMAR in patients with normal...
Telemedicine retinopathy of prematurity (ROP) screening
5 June 2020
| Ivan Yip
|
Retina / Uvea / Vitreous
|
etinopathy of prematurity, screening, telemedicine
The Auckland Regional Telemedicine ROP network utilises wide-field digital imaging for ROP screening. Results are from 2006-2015; 1181 infants were screened over three neonatal intensive care units; 83 infants with ROP were identified. Screening rates increased over the 10 years...
Cytokine levels in vitreous fluid in patients with pathological myopia
1 April 2020
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
Pathological myopia (PM) is a leading cause of irreversible visual impairment worldwide, and efforts are dedicated to the study of its underlying mechanisms. Axial extension of the eyeball is regulated via a cascade of biochemical molecules that are initiated in...
Hypothyroidsim and acute central serous chorioretinopathy – is there a link?
1 April 2020
| Su Young
|
Retina / Uvea / Vitreous
This cross-sectional study included 71 consecutive acute central serous chorioretinopathy (CSC) patients and 70 age-matched healthy control subjects. Systemic findings, including serum levels of thyroid hormones, thyroid stimulating hormone (TSH), mean arterial pressure (MAP), pulse rate, serum lipid levels and...
Comparison between findings in OCTA and FA in patients with diabetic retinopathy
1 April 2020
| Sofia Rokerya
|
Retina / Uvea / Vitreous
In this study the authors present a prospective cross-sectional comparative study of typical findings of diabetic retinopathy to analyse the agreement between the image modalities of optical coherence tomography angiography (OCTA) and fluorescein angiography (FA). Fifty-three eyes of 42 patients...
Results of fixed aflibercept treatment regime in type 3 neovascularisation
1 April 2020
| Sofia Rokerya
|
Retina / Uvea / Vitreous
In this prospective study the authors evaluate the effect of intravitreal aflibercept injections in the treatment of naive type 3 neovascularisation using a fixed treatment regime. Fourteen eyes of 14 patients were studied. All patients were treated with intravitreal 2.0...
Retinal ischaemia on OCTA and diabetic retinopathy grade
1 April 2020
| Saruban Pasu
|
Retina / Uvea / Vitreous
The authors quite rightly point out that quantification of retinal ischaemia has the potential to serve as a biomarker for diabetic retinopathy disease progression. They set out to investigate the relationship between area of ischaemia on a swept source OCTA...
